Product logins

Find logins to all Clarivate products below.


Spinal Implants | Market Insights | Asia Pacific | 2021

While the COVID-19 pandemic will significantly impact the market in the short term, other factors, such as favorable demographics and increased access to health care in some of the countries covered, will ultimately lead to growth in the Asia Pacific spinal implant market through 2029. Although the spinal implant market will be somewhat limited by pricing pressures, challenging reimbursement environments, and nationalist policies in China and India, advancements in medical facilities and an increased focus on physician training will lead to overall spinal implant market growth.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for spinal implants in the Asia Pacific region across a 10-year period.

Related Medtech Insights Reports

Report
Sports Medicine Devices – Market Insights – Japan
Technological investments, adoption of premium-priced products, increased market awareness through educational programs, improved surgeon training, and high levels of sports participation will…
Report
Craniomaxillofacial Devices – Market Insights – United States
Growth in the US CMF device market will be primarily driven by favorable demographics, continuous improvements in physician training, and ongoing development of additive manufacturing. Additionally…
Report
Sports Medicine Devices – Market Insights – United States
The US sports medicine device market will grow modestly through 2034, driven by improved surgeon training and the adoption of premium-priced products. However, the pricing pressure brought on by…
Report
Interventional Oncology Devices – Market Insights – Asia Pacific
The Asia Pacific interventional oncology device market will see strong growth through 2034, driven by updated clinical guidelines, broader access to minimally invasive cancer treatments, and…
Report
Electrophysiology Mapping and Ablation Devices – Market Insights – Asia Pacific
The Asia Pacific EP mapping and ablation device market will experience strong growth through 2034, driven by rising procedure volumes, new product launches, increasing prevalence of cardiac…